August 30, 2018
Purdue Pharma LP has agreed to pay Assertio Therapeutics Inc., formerly known as Depomed Inc., $62 million in cash to settle claims in New Jersey federal court that Purdue's blockbuster opioid painkiller OxyContin infringed two of Assertio's patents.
November 26, 2013
A New Jersey federal judge on Tuesday declined to split into two phases any such trial in Depomed Inc.'s suit alleging Purdue Pharma LP's pain reliever OxyContin infringed on three of its patents for extended-release drug technology, saying bifurcation isn't warranted.